Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. by Gourraud, Pierre-Antoine et al.
UCSF
UC San Francisco Previously Published Works
Title
Linkage disequilibrium organization of the human KIR superlocus: implications for KIR 
data analyses.
Permalink
https://escholarship.org/uc/item/5fh3c4hg
Journal
Immunogenetics, 62(11-12)
ISSN
0093-7711
Authors
Gourraud, Pierre-Antoine
Meenagh, Ashley
Cambon-Thomsen, Anne
et al.
Publication Date
2010-12-01
DOI
10.1007/s00251-010-0478-4
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ORIGINAL PAPER
Linkage disequilibrium organization of the human KIR
superlocus: implications for KIR data analyses
Pierre-Antoine Gourraud & Ashley Meenagh &
Anne Cambon-Thomsen & Derek Middleton
Received: 2 April 2010 /Accepted: 2 September 2010 /Published online: 29 September 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract An extensive family-based study of linkage
disequilibrium (LD) in the killer cell immunoglobulin-like
receptors (KIR) cluster was performed. We aimed to describe
the LD structure in the KIR gene cluster using a sample of 418
founder haplotypes identified by segregation in a group of 106
families from Northern Ireland. The LD was studied at two
levels of polymorphism: the structural level (presence or
absence of KIR genes) and the allelic level (between alleles of
KIR genes). LD was further assessed using the predictive
value of one KIR polymorphism for another one in order to
provide an interpretative framework for the LD effect in
association studies. In line with previous research, distinct
patterns of KIR genetic diversity within the genomic region
centromeric to KIR2DL4 (excluding KIR2DL4) and within
the telomeric region including KIR2DL4 were found. In a
comprehensive PPV/NPV-based LD analysis within the KIR
cluster, robust tag markers were found that can be used
to identify which genes are concomitantly present or absent
and to further identify groups of associated KIR alleles.
Several extended KIR haplotypes in the study population
were identified (KIR2DS2*POS–KIR2DL2*001–
KIR2DL5B*002–KIR2DS3*00103–KIR2DL1*00401;
KIR2DL4*011–KIR3DL1/S1*005–KIR2DS4*003–
KIR3DL2*003; KIR2DL4*00802–KIR3DL1/S1*004–
KIR2DS4*006–KIR3DL2*005; KIR2DL4*00801–
KIR3DL1/S1*00101–KIR2DS4*003–KIR3DL2*001;
KIR2DL4*00103–KIR3DL1/S1*008–KIR2DS4*003–
KIR3DL2*009; KIR2DL4*00102–KIR3DL1/S1*01502/
*002–KIR2DS4*00101–KIR3DL2*002; KIR2DL4*00501–
KIR3DL1/S1*013–KIR2DL5A*001–KIR2DS5*002–
KIR2DS1*002–KIR3DL2*007). The present study provides
a rationale for analyzing associations of KIR polymorphisms
by taking into account the complex LD structure of the KIR
region.
Keywords KIR . Linkage disequilibrium . Tagging .
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Introduction
Natural killer (NK) cells are key components of the innate
immune response. According to the missing-self model,
NK cells integrate activating and inhibitory signals and
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modulate the targeting of MHC Class I-deficient cells, in
particular virus-infected and transformed malignant cells
(Bashirova et al. 2006). NK cells maintain wide-ranging
interactions with other immune cells, such as macrophages
and dendritic cells, resulting in numerous effects on the
immune response as a whole through the stimulation of
cytokine production and induction of cytotoxicity (Carrington
andMartin 2006). NK cells may provide benefit or act to the
detriment of to the host: They play a central role not only in
viral clearance (Khakoo et al. 2004; Martin et al. 2007),
cancer (Middleton et al. 2009; Verheyden and Demanet
2008), and hematopoietic stem cell transplantation (Velardi
2008) but also in the development of autoimmune disorders
(Lowe et al. 2009; Ploski et al. 2006) and less common
conditions such as pre-eclampsia (Hiby et al. 2008).
The NK cell receptors consist of two distinct families, C-
type lectin-like group (CD94/NKG2) mapping to chromosome
12q1.3-13.4 and the immunoglobulin-like super family
consisting of the killer cell immunoglobulin-like receptors
(KIR), leukocyte immunoglobulin-like receptors, and the
leukocyte-associated immunoglobulin-like receptors mapping
to chromosome 19q13.4 (Bashirova et al. 2006; Carrington and
Martin 2006). The KIR gene cluster has generated great
interest due to its complex genetic variability (Bashirova et al.
2006; Carrington and Martin 2006; Middleton et al. 2007;
Parham 2005).
KIR genes may be either present or absent, leading to
substantial variation in gene content across individuals and
populations. The deletion and/or duplication of KIR genes
occur frequently, creating great structural variation and
generating a variable number of copies of KIR genes
relative to a reference sequence (i.e., the most frequent one;
Hsu et al. 2002). When present, individual KIR genes show
high allelic polymorphisms. Their frequencies vary across
populations, some being common, others rare. The patterns
of gene presence or absence and allelic polymorphism
combine to generate a high degree of KIR heterogeneity
between individuals (Middleton and Gonzelez 2010). The
polymorphism of genes in the KIR cluster may be assessed
at two levels: the structural variation (also known as copy
number variation, CNV) of genes and the allelic variation
of each gene.
Linkage disequilibrium (LD) is the nonrandom association
of alleles at two or more neighboring loci. Furthermore,
because KIR genes are arrayed in tandem over more than
150 kb (Uhrberg et al. 1997), extensive LD implicates both
gene content and allelic variation (Shilling et al. 2002). Such
complex LD patterns, already complicated in pedigree
analyses, may lead to ambiguous interpretation in population
association studies because nonindependent associations
between KIR genes or alleles may result in potential
synergistic or antagonist functional effects. This complexity
may explain the difficulty encountered in replication of
disease CNV genetic association studies. The KIR cluster
can be considered as a model region for CNV genomics,
because it is the most important region outside the MHC
establishing the functional role for variation in the number of
genes. The complexity of KIR genetics increases the risk for
false-positive findings and misinterpretation of genetic
associations, particularly in studies with small sample size,
requiring the development of improved analytical methods
and better characterization of control populations. In the
present study using predictive values, we provide a statistical
description of LD that aids in the interpretation of
associations between KIR polymorphisms.
The LD tagging approach identifies a single genetic
position that marks a block of positions in LD with one
another (Gu et al. 2008; Johnson et al. 2001). This approach
helps to deal with the complexity of the haplotype structure
by measuring whether the different polymorphisms (genes
and/or alleles) carry different or redundant information. The
tagging concept applies LD between KIR genes in order to
help understand the complex associations observed in KIR
haplotypes.
LD studies require haplotype frequency data. To supplement
the lack of phase information in standard genotyping, haplotypes
can be experimentally deduced from segregation analysis of
pedigrees. Thus far, only numerous-offspring or multigenera-
tional pedigree studies have been able to appropriately address
both phase information and dose ambiguity (Martin et al. 2008;
Middleton et al. 2007). However, KIR typing of families
requires a lot of resources, and such homogeneous samples of
families typed for KIR are limited (Martin et al. 2008).
Describing the LD structure in the KIR gene cluster using
founder haplotypes from existing family data would provide an
interesting analytical tool for in-depth KIR analysis in
nonfamily cases, such as genetic association analyses.
In the present study, we performed an extensive family-
based study of LD in the KIR cluster, with the aim of
describing the LD structure in the KIR gene cluster using
founder haplotypes (Middleton et al. 2007). LD was
sequentially studied at two levels: the structural level of
LD (between presence or absence of KIR genes) and the
allelic level of LD (between alleles of KIR genes). The KIR
cluster LD was analyzed using the tagging concept outlined
above and predictive values.
Dataset and methods
For this study, 106 families from Northern Ireland with
numerous offspring and complex pedigrees were recruited.
Three parents were available in one family. Genotyping
DNA from this set of families allowed the identification of
426 founder haplotypes, which are the actual statistical unit
of the study. The typing protocols used were the same as in
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a previous publication in which 77 of the 106 families were
reported (Middleton et al. 2007). Because DNA specimens
were lacking for some individuals, eight haplotypes with
only partial typing at the allelic level were excluded. Thus,
a total of 418 haplotypes were included in this analysis.
Informed consent was obtained prior to sample collection.
Only anonymous data, which protect the privacy rights of
the persons involved and their family, were used in the
analyses.
The following KIR genes were studied (listed in
consensus order from the most centromeric to the most
telomeric): KIR3DL3, KIR2DS2, KIR2DL3, KIR2DL2,
KIR2DL5B, KIR2DS3, KIR2DL1, KIR2DL4, KIR3DL1,
KIR3DS1, KIR2DL5A, KIR2DS5, KIR2DS1, KIR2DS4,
and KIR3DL2. The physical gene position is a consensus
map, and another order may better reflect the reality of a
given haplotype. Although LD computations do not use the
physical positions of the genes and their alleles, LD
measures are not necessarily independent of gene order.
For example, this is the case when one considers the
possibility of KIR2DS3 and KIR2DS5 being present on
either side or both sides of KIR2DL4. Each gene was typed
to the allelic level, except KIR2DS2 and KIR3DL3. All
parents were positive for KIR3DL3, although it is not
possible to ensure that two copies are present; KIR3DL3
was considered to be always present. Allele typing together
with segregation analysis allows the dose ambiguity in all
other situations to be ascertained (Middleton et al. 2007).
The two historical KIR haplotype arrangements, A and
B, were identified in relation to the typed KIR genes
according the definition of (Middleton et al. 2007). Briefly,
the basis of each A or B haplotype consists of four
framework genes: KIR2DL4, KIR3DL2, KIR3DL3, and
KIR3DP1. The A haplotype contains eight genes, those of
this framework plus KIR2DL1, KIR2DL3, KIR2DS4, and
KIR3DL1. The B haplotype is defined by the presence of
one or more of the activating KIR genes in addition to the
framework: KIR2DS1/2/3/5 genes, KIR3DS1, and the
inhibitory genes KIR2DL5A/B and KIR2DL2. Several
genes (KIR2DL1, KIR2DL3, KIR2DS4, and KIR3DL1)
normally associated with the A haplotype can be found in
the B haplotype. Only when all four are present was the
haplotype considered to be the A haplotype. Among the
418 haplotypes studied, 230 (55.02%, with a 95%
confidence interval (CI) of 50.11–59.86) were A haplotypes
and 188 (44.98%, 95% CI of 40.14–49.89) were B
haplotypes.
First, at the structural variation level, the LD is between
the presence or absence of KIR genes, where KIR genes are
taken as biallelic markers. KIR3DL3 and KIR3DL2 were
assumed to be always present, preventing the assessment of
LD between these genes. In the segregation analysis and
allele typing, KIR2DL4 was shown to be missing in two
haplotypes. This made it possible to compute LD for
presence/absence between KIR2DL4 and the other KIR
genes that may be present or absent. Second, LD between
alleles of KIR genes was studied. KIR3DL2, which was
always present in the studied sample, was not considered in
LD computations. However, alleles of KIR3DL2 were
considered in the second part of the analysis.
Haplotype frequencies were computed by gene counting.
The total number of haplotypes used in the estimation is
418. It remained the same throughout the LD analyses.
Furthermore, to better address which KIR genes are
preferentially associated, positive predictive value (PPV)
and negative predictive value (NPV) were used. PPV and
NPV are computed using one allele/gene as the tagging
marker and another gene/allele as the tagged/targeted
marker. PPV is defined as the probability of occurrence of
the targeted marker given the presence of the tagging
marker. NPV is defined as the probability of absence of the
targeted marker given the absence of the tagging marker.
Each parameter is calculated as the marginal probability of
the corresponding 2×2 table. PPV and NPV are commonly
used in epidemiology and have been used to better describe
polymorphism associations in the MHC region (Foissac et
al. 2001). As classically performed for insertion/deletion
(indel) polymorphisms, the absence of a KIR gene is
considered as an allele and, therefore, can serve as the
tagging marker of alleles at other loci. In order to avoid
associations that may occur due to sampling fluctuations, a
minimal frequency of 5% (20 occurrences) was applied.
The computational and graphical display of matrix of D′
LD measures was performed in the Haploview software
package (a SNP-oriented software (Barrett et al. 2005)
implementing tagging algorithms) as well as the Gold
software (Abecasis and Cookson 2000). Both are publicly
available. The PPV/NPV-based LD analysis was performed
with the STATA ver. 10 software (Stata Corp LP, College
Station, TX, USA).
Results
First, we analyzed the distribution of KIR genes as copy
number variants in the familial dataset (presence or absence
of each KIR gene) and their associations. A parsimonious
tagging strategy of KIR haplotype structural diversity was
derived, leading to the quantification of the tagging ability
of KIR genes toward KIR haplotype structure. Second, we
analyzed those alleles of KIR genes that are in LD.
Figure 1 displays D′ pairwise LD metrics between the
presence and absence of 13 KIR genes (all but KIR3DL2
and KIR3DL3, which are always present). In this approach
to assess KIR LD, the KIR cluster genetic polymorphism is
reduced to presence (POS) or absence (NEG) of KIR genes
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(Fig. 1). Higher D′ values appear toward the darker end of
the gray scale and lower D′ values appear toward the lighter
end. LD in KIR splits around the KIR2DL4 gene, clearly
demarcating two regions, one centromeric (KIR3DL3,
KIR2DS2, KIR2DL3, KIR2DL2, KIR2DL5B, KIR2DS3,
and KIR2DL1) and one telomeric (KIR2DL4, KIR3DL1,
KIR3DS1, KIR2DL5A, KIR2DS5, KIR2DS1, KIR2DS4,
and KIR3DL2). In the centromeric region, KIR2DL5B and
KIR2DS3 display moderate LD with genes of the telomeric
region, with the exception of KIR2DS5. In the telomeric
region, KIR2DL4 is in moderate LD with the genes of the
centromeric region, in particular KIR2DL3. Hereafter, the
subdivision of the KIR cluster into two regions was adopted
as a suitable way to describe LD in the KIR region.
As shown in Fig. 2, the population distribution of KIR
gene haplotype structural diversity can be visually repre-
sented in a compact manner. Haplotypes are read following
the thin (frequency between 0.3% and 10 %) and thick
(frequency greater than 10%) connecting lines between the
centromeric and telomeric regions. Haplotypes whose
frequencies are less than 0.3% are not connected because
the sample size does not allow the distinction of preferential
associations from a rare pattern combination. As suggested
by the branching of connecting lines, multiple events of
recombination between KIR2DL1 and KIR2DL4 are
needed to generate the observed structural diversity of
these haplotypes of the centromeric and telomeric regions.
The structural diversity of the haplotypes in both regions
suggests multiple events of duplication and/or deletion of the
genes as well as the selection and/or genetic drift events that
occurred in the Northern European population. In the
centromeric region, three gene structural haplotypes represent
93.8% of the haplotypes observed in our sample. In the
telomeric region, two gene structural haplotypes represent
92.4%. The low LD (0.36) between regions suggests that
multiple ancestral recombination events occurred between
KIR2DL4 and KIR2DL1. Individuals bearing the haplotypes
generated by such events do not seem to have been eliminated
by selection or genetic drift. As expected, the structural
diversity of B haplotypes is much greater than that of A
haplotypes. The figure illustrates that the A or B haplotype
definition depends on how the various structural haplotypes of
both regions combine.
Subdividing the KIR cluster into two regions of LD, as
displayed in Fig. 2, simplifies the description of the KIR
genes’ haplotype structure. As commonly performed for
SNPs, a tagging strategy was applied to the gene structural
variation level of KIR haplotypes. The analysis revealed
limited structural variation patterns (number of instances of
presence or absence of KIR genes that are always
associated). Table 1 presents the tagging approach derived
from haplotype frequencies. Studying six genes is sufficient
to account for the haplotype structural diversity observed in
the 13 member genes. These associations of presence and/
79
79
79
100
99
99
99 87
84
Telomeric LD Region Centromeric LD Region
100
100100
39
52
62
Fig. 1 Pairwise linkage disequilibrium between the presence or absence
of 13 KIR genes. Lewontin’s pairwise standardized metrics describe
linkage disequilibrium (LD) between all KIR genes but KIR3DL2 and
KIR3DL3 which were thought to be always present. KIR genes are
considered at the structural variation level (the presence or absence level;
copy number variant). Computations were double-checked using Haplo-
view software (a SNP-oriented software) as well as the combined use of
Gold software for graphical display and Stata ver. 10.0 SE for computing
the LD metrics. KIR3DL1 and KIR3DS1 are considered as two different
genes. The physical gene position is a consensus map, and another order
may better reflect the reality of a given haplotype. Although LD
computations do not use the physical positions of the genes and their
alleles, LD measures are not necessarily independent of gene order. For
example, this is the case when one considers the possibility of 2DS3 and
2DS5 being present on either side or both sides of 2DL4
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or absence of KIR genes introduce a structural framework
for further KIR allelic diversity. The definition of the
presence or absence of these six genes is sufficient to determine
the presence or absence of all other genes in a single haplotype
(r2=0.8). That is, the status (present or absent) of the 13 KIR
genes in a haplotype can be deduced from the presence or
absence of six of them. It is worth noting that most of the
tagging is achieved within each LD region (centromeric or
telomeric). Interestingly, a nonpairwise LD component test
(test 7, Table 1) has to be used to identify KIR2DL5B using
the simultaneous presence of KIR2DL2–KIRD2S3 as a
tagging marker, meaning that KIR2DL5B is present when
both KIR2DL2 and KIR2DS3 are present. Unlike the other
tagging genes, the absence (not the presence) of KIR3DL1 is
(A/B) -.648
(B) -.163
(B) -.127
(B) -.022
(B) -.012
(B) -.007
(B) -.005
(B) -.005
(B) -.002
(B) -.002
(B) -.002
(B) -.002
(B) -.002
.766-(A/B)
.012-(B)
.158-(B)
.031-(B)
.002-(B)
.002-(B)
.002-(B)
.005-(B)
.005-(B)
.002-(B)
.002-(B)
.005-(B)
LD between regions
D’=0.36
.007-(B)
Centromeric LD region Telomeric LD region
S
S
S
S
S
L
L
L
L
L
L
SL
Fig. 2 Compact illustration of the KIR genes framework haplotype using
centromeric and telomeric regions. Lines indicate associations of
telomeric and centromeric regions. Thin lines connect haplotypes whose
frequency is between 0.3% and 10%. Thick lines connect haplotype
whose frequency is greater than 10%. Rectangles indicate presence of
the KIR gene, and lines represent absence of the KIR gene. All
haplotype structures within the sample are displayed. This figure also
presents a specific D′: the Hedrick’s multiallelic D′, which represents the
degree of LD between two regions, treating each haplotype within a
region as an allele. The display is adapted from the Haploview software
haplotype blocks display. KIR3DL2 is always present at the telomeric
end. (*) KIR3DL3 is assumed to be always present but was not typed at
the allelic level in the families. All founders and offspring were positive
for KIR3DL3. Because KIR3DL3 and KIR3DL2 appear to be always
present, it is not possible to study LD for these genes in terms of their
presence or absence. The physical gene position is a consensus map, and
another order may better reflect the reality of a given haplotype.
Although LD computations do not use the physical positions of the
genes and their alleles, LD measures are not necessarily independent of
gene order. For example, this is the case when one considers the
possibility of 2DS3 and 2DS5 being present on either side or both sides
of 2DL4. Frequencies and membership in the A or B haplotype are
displayed on the side of the haplotypes. For example, in the centromeric
region, the haplotype KIR3DL3–KIR2DL3–KIR2DL1 can belong to
both A and B haplotypes and its frequency in our data is 0.648 (64.8%),
it combines in more than 10% of the cases with KIR2DL4–KIR3DS1–
KIR2DL5A–KIR2DS1–KIR3DL2 telomeric haplotype, which is found
in B haplotypes and whose frequency is 15.8%
Table 1 Tagging strategy of KIR genes using LD between genes to minimize the number of KIR genes to study
Test KIR genes KIR genes captured through LD
1 Absence of KIR3DL1 KIR2DL5A; KIR3DS1; KIR2DS1; absence of KIR2DS4
2 KIR2DL2 KIR2DS2; absence of KIR2DL3
3 KIR2DS5
4 KIR2DS3
5 KIR2DL4
6 KIR2DL1
7 KIR2DL2–KIRD2S3 KIR2DL5B
According to the haplotype display in Fig. 2, a parsimonious strategy of testing for the presence or absence of KIR genes can be drawn. The 13
genes can be tested using six genes and seven tests. In the tagging approach, KIR2DL3, KIR3DL1, and KIR2DS4 differ from the other genes
because it is not the genes themselves that are taken into account but their absence. Test 7 corresponds to the simultaneous presence of KIR2DL2
and KIR2DS3. Test 7 cannot be directly inferred from the data in Table 2 and must consider KIR2DL2–KIR2DS3 or KIR2DS2–KIR2DS3
structural haplotypes to capture the KIR2DL5B gene (Fig. 2)
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taken into account. Similarly, unlike other tagged genes,
KIR2DS4 and KIR2DL3 are deduced to be absent instead of
present. With regard to tests 4 and 5, even if KIR2DS3 and
KIR2DL4 are in complete LD with one another, they are
embedded in different haplotypes and need to be tested
separately. In addition, with an r2=0.87 (not shown), the
absence of KIR3DL1 tagging the absence of KIR2DS4 is the
least efficient tagging relationship. For studies in which not all
KIR genes are typed, such a table can help extend the possible
interpretation to other untyped KIR genes.
Association studies more conveniently handle pairwise
relationships among genes. For example, it is commonly
noted that KIR2DL2 and KIR2DS2 are “preferentially
associated” with one another. To both quantify and
generalize such a statement to any pair of KIR genes, in
addition to Table 1, Supplementary Tables S1 and S2 for
the centromeric region and S3 and S4 for the telomeric
region present PPVs and NPVs between the presence or
absence of all KIR genes. PPVs quantify associations due
to both LD and high frequency of the reference haplotype.
For example, when KIR2DS2 is absent, there is a 100%
chance that KIR2DL2 is absent as well and an 82.39%
chance that KIR2DS4 is present (PPVs). Similarly for
NPVs, when KIR2DS4 is NOT present, there is a 39.33%
chance that KIR2DL2 is present and a 94.38% chance that
KIR2DS1 is present.
We now present results for LD at the allelic level
(preferential association of alleles). KIR3DL1 and
KIR3DS1 are considered as mutually exclusive alleles of
the same gene (the “KIR3DL1/S1” locus): the simultaneous
presence in cis of the KIR3DL1 and KIR3DS1 alleles can
occur and is considered as a specific KIR3DL1/S1 allele. It
includes haplotypes that have two copies of one gene
(Middleton et al. 2007). This analysis includes KIR3DL2,
which is always present but shows allelic variation. Data on
LD between genes were computed using allelic informa-
tion. Tables 2 and 3 present, respectively, the highest LD
components between KIR alleles in the centromeric LD
region (KIR2DL3, KIR2DL2, KIR2DL5B, KIR2DS3,
KIR2DL1) and in the telomeric LD region (KIR2DL4,
Table 2 KIR gene alleles of the centromeric LD region tagging other KIR gene alleles
KIR tagging allele KIR tagged allele PPV NPV Haplotype frequency D' (*)
KIR2DL3 *002 KIR2DL1*002 94.30% 99.70% 23.90% 0.45
*001 KIR2DL1*00302 94.80% 96.60% 35.20% 0.45
KIR2DL2 *003 KIR2DS2*POS 100.00% 77.60% 12.40% 0.79
*001 KIR2DS2*POS 100.00% 83.30% 18.40% 0.79
*001 KIR2DL5B*002 71.40% 99.40% 13.20% 0.95
KIR2DL5B *002 KIR2DS2*POS 98.20% 78.40% 13.40% 0.97
*002 KIR2DL1*00401 78.90% 98.10% 10.80% 0.82
*002 KIR2DS3*00103 84.20% 98.60% 11.50% 0.84
*002 KIR2DL2*001 96.50% 93.90% 13.20% 0.95
KIR2DS3 *00103 KIR2DS2*POS 90.60% 76.40% 11.50% 0.79
*00103 KIR2DL1*00401 69.80% 95.90% 8.90% 0.77
*00103 KIR2DL5B*002 90.60% 97.50% 11.50% 0.84
*00103 KIR2DL2*001 86.80% 91.50% 11.00% 0.79
KIR2DL1 *00401 KIR2DS2*POS 100.00% 77.60% 12.40% 0.75
*00401 KIR2DL5B*002 86.50% 96.70% 10.80% 0.82
*00401 KIR2DS3*00103 71.20% 95.60% 8.90% 0.77
*00401 KIR2DL2*001 84.60% 91.00% 10.50% 0.74
*00302 KIR2DL3*001 94.20% 96.90% 35.20% 0.45
*002 KIR2DL3*002 99.00% 98.10% 23.90% 0.45
Only alleles of the previously defined centromeric region are displayed. Other constraints were applied: tagging must have a minimal PPVof 65%.
For robustness of the estimation, only haplotypes of more than 5% were studied; haplotypes without KIR gene at another locus were not studied.
(*) PPV and NPV drastically differ from D′. PPV and NPV are measures of association at the allelic level, whereas D′ is a locus-level average
measure of LD. D′ stands for the pairwise standardized Hedrick’s measure of LD between multiallelic genes. Confidence intervals can be
computed because frequencies were estimated by gene counting. The total number of haplotypes is 418 (~209 founders of the families). For
example (2nd row), the probability of having KIR2DL1*00302 given the presence of KIR2DL3*001 is 94.8%, the probability of not having
KIR2DL1*00302 given the absence of KIR2DL3*001 is 96.6%, the KIR2DL3*001–KIR2DL1*00302 haplotype frequency is 35.2%, and D′
between KIR2DL3 and KIR2DL1 is 0.45
PPV positive predictive value, the probability of the tagged KIR allele given the presence of the tagging KIR allele; NPV negative predictive
value, the probability of the absence of the tagged KIR allele given the absence of the tagging KIR allele
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Table 3 KIR gene alleles of the telomeric LD region tagging other KIR genes alleles
KIR tagging allele KIR tagged allele PPV NPV Haplotype Frequency D′ (*)
KIR2DL4 *011 KIR3DL1/S1*005 100.00% 99.70% 13.60% 0.21
*011 KIR2DS4*003 100.00% 72.30% 13.60% 0.49
*011 KIR3DL2*001 77.20% 85.90% 10.50% 0.27
*00802 KIR2DS4*006 98.60% 99.40% 16.70% 0.49
*00802 KIR3DL1/S1*004 95.80% 99.70% 16.30% 0.21
*00801 KIR2DS4*003 94.90% 75.60% 17.70% 0.49
*00801 KIR3DL1/S1*00101 89.70% 99.70% 16.70% 0.21
*00501 KIR3DL1/S1*013 93.80% 99.70% 18.20% 0.21
*00501 KIR3DL2*007 95.10% 97.60% 18.40% 0.27
*00501 KIR2DS1*002 100.00% 97.60% 19.40% 0.71
*00501 KIR2DS5*002 82.70% 98.80% 16.00% 0.86
*00501 KIR2DL5A*001 79.00% 99.40% 15.30% 0.69
*00103 KIR3DL2*009 81.30% 99.20% 6.20% 0.27
*00103 KIR3DL1/S1*008 75.00% 100.00% 5.70% 0.21
*00103 KIR2DS4*003 71.90% 65.30% 5.50% 0.49
*00102 KIR3DL2*002 100.00% 99.10% 17.50% 0.27
*00102 KIR2DS4*00101 98.60% 96.80% 17.20% 0.49
KIR3DL1/S1 *01502 KIR3DL2*002 100.00% 89.30% 8.40% 0.25
*01502 KIR2DL4*00102 100.00% 90.10% 8.40% 0.21
*01502 KIR2DS4*00101 97.10% 87.20% 8.10% 0.47
*013 KIR3DL2*007 94.80% 96.50% 17.50% 0.25
*013 KIR2DL4*00501 98.70% 98.50% 18.20% 0.21
*013 KIR2DS1*002 100.00% 96.50% 18.40% 0.71
*013 KIR2DS5*002 81.80% 97.70% 15.10% 0.84
*013 KIR2DL5A*001 77.90% 98.20% 14.40% 0.69
*008 KIR2DS4*003 95.80% 66.00% 5.50% 0.47
*008 KIR2DL4*00103 100.00% 98.00% 5.70% 0.21
*005 KIR2DL4*011 98.30% 100.00% 13.60% 0.21
*005 KIR2DS4*003 98.30% 72.20% 13.60% 0.47
*005 KIR3DL2*001 75.90% 85.80% 10.50% 0.25
*004 KIR2DL4*00802 98.60% 99.10% 16.30% 0.21
*004 KIR2DS4*006 98.60% 98.90% 16.30% 0.47
*002 KIR3DL2*002 100.00% 89.50% 8.60% 0.25
*002 KIR2DL4*00102 100.00% 90.30% 8.60% 0.21
*002 KIR2DS4*00101 100.00% 87.70% 8.60% 0.47
*00101 KIR2DL4*00801 98.60% 97.70% 16.70% 0.21
*00101 KIR2DS4*003 95.80% 74.40% 16.30% 0.47
KIR2DL5A *001 KIR3DL1/S1*013 90.90% 95.20% 14.40% 0.69
*001 KIR3DL2*007 95.50% 93.80% 15.10% 0.8
*001 KIR2DL4*00501 97.00% 95.20% 15.30% 0.69
*001 KIR2DS1*002 100.00% 93.50% 15.80% 0.85
*001 KIR2DS5*002 100.00% 98.60% 15.80% 0.83
KIR2DS5 *002 KIR3DL1/S1*013 88.70% 96.00% 15.10% 0.84
*002 KIR3DL2*007 95.80% 95.10% 16.30% 0.84
*002 KIR2DL4*00501 94.40% 96.00% 16.00% 0.86
*002 KIR2DS1*002 100.00% 94.80% 17.00% 0.87
*002 KIR2DL5A*001 93.00% 100.00% 15.80% 0.83
KIR2DS1 *002 KIR3DL1/S1*013 86.50% 100.00% 18.40% 0.71
*002 KIR3DL2*007 92.10% 99.10% 19.60% 0.86
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KIR3DL1/KIR3DS1, KIR2DL5A, KIR2DS5, KIR2DS1,
KIR2DS4, KIR3DL2). Only tagging relations that have a
minimal PPV of 65% are displayed. For robust estimation,
only haplotypes with a frequency over 5% were studied.
As expected, strong LD between KIR genes (as measured
by D′) is driven by specific allelic associations (high PPV,
high NPV, and high D′; Table 2). For example, while
KIR2DS3 and KIR2DL1 are in strong LD (D′ computed
with alleles=0.77), KIR2DS3*00103 specifically associates
with KIR2DL1*00401: KIR2DL1*00401 is present in
69.8% of the cases when KIR2DS3*00103 is present (i.e.,
PPV=69.8%). Interestingly, several alleles of KIR genes that
are not in strong LD were found to tag each other (high PPV,
high NPVat allelic level, and low D′ at averaged level between
loci). That is the case for two allelic associations between
KIR2DL1 and KIR2DL3 (D′ computed with alleles = 0.45):
KIR2DL1*00302 tags KIR2DL3*001 (PPV=94.2%, NPV=
96.9%) and KIR2DL1*002 tags KIR2DL3*002 (PPV=99.0%,
NPV=98.1%). In addition to the balance between KIR2DS2
and KIR2DL2*001 associated with KIR2DL5B*002,
KIR2DS3*00103 and KIR2DL1*00401 may have a specific
role in tuning the NK cell response. The data in Table 2 thus
suggest the existence of very strong LD spanning the
centromeric KIR region: KIR2DS2*POS–KIR2DL2*001–
KIR2DL5B*002–KIR2DS3*00103–KIR2DL1*00401
(as listed in Table 4), as each of these genes/alleles has a high
PPV.
The telomeric LD regions show more allele diversity as
well as a greater number of tagging-like relationships
between KIR alleles (Table 3). As observed in the
centromeric region, strong LD between KIR genes is driven
by specific allelic association (high PPV, high NPV, and
Table 3 (continued)
KIR tagging allele KIR tagged allele PPV NPV Haplotype Frequency D′ (*)
*002 KIR2DL4*00501 91.00% 100.00% 19.40% 0.71
*002 KIR2DS5*002 79.80% 100.00% 17.00% 0.87
*002 KIR2DL5A*001 74.20% 100.00% 15.80% 0.85
KIR2DS4 *006 KIR2DL4*00802 97.20% 99.70% 16.70% 0.49
*006 KIR3DL1/S1*004 94.40% 99.70% 16.30% 0.47
*00101 KIR3DL2*002 89.20% 99.40% 17.70% 0.62
*00101 KIR2DL4*00102 86.70% 99.70% 17.20% 0.49
KIR3DL2 *011 KIR2DL4*00801 95.70% 85.80% 5.30% 0.27
*011 KIR2DS4*003 91.30% 65.60% 5.00% 0.62
*009 KIR2DL4*00103 89.70% 98.50% 6.20% 0.27
*007 KIR3DL1/S1*013 85.90% 98.80% 17.50% 0.25
*007 KIR2DL4*00501 90.60% 98.80% 18.40% 0.27
*007 KIR2DS1*002 96.50% 97.90% 19.60% 0.86
*007 KIR2DS5*002 80.00% 99.10% 16.30% 0.84
*007 KIR2DL5A*001 74.10% 99.10% 15.10% 0.8
*005 KIR2DL4*00802 92.10% 90.50% 8.40% 0.27
*005 KIR2DS4*006 94.70% 90.50% 8.60% 0.62
*005 KIR3DL1/S1*004 86.80% 90.50% 7.90% 0.25
*003 KIR2DL4*00802 93.90% 89.60% 7.40% 0.27
*003 KIR2DS4*006 97.00% 89.60% 7.70% 0.62
*003 KIR3DL1/S1*004 93.90% 90.10% 7.40% 0.25
*002 KIR2DL4*00102 96.10% 100.00% 17.50% 0.27
*002 KIR2DS4*00101 97.40% 97.40% 17.70% 0.62
*001 KIR2DS4*003 95.80% 79.60% 21.80% 0.62
Only alleles of the previously defined central telomeric region are displayed. Other constraints were applied: Tagging must have a minimal PPVof
65%. For robustness of the estimation, only haplotypes of more than 5% were studied; haplotypewithout the KIR gene at another locus were not
studied. (*) PPV and NPV drastically differ from D′. PPV and NPV are measures of association at the allelic level, whereas D′ is a locus-level
average measure of LD. Confidence intervals can be computed because frequencies were estimated by gene counting. The total number of
haplotype is 418 (~209 founders of the families). For example, (1st row) the probability of having KIR3DL1/S1*005 given the presence of
KIR2DL4*011 is 100.0%, the probability of not having KIR3DL1/S1*005 given that KIR2DL4*011 is absent in 99.7%, the KIR3DL1/S1*005–
KIR2DL4*0011 haplotype frequency is 13.6%, and D′ between KIR2DL4 and KIR3DL1/S1 is 0.21
PPV positive predictive value, the probability of the tagged KIR allele given the presence of the tagging KIR allele; NPV negative predictive
value, the probability of the absence of the tagged KIR allele given the absence of the tagging KIR allele
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high D ′) . For example, KIR3DL1/S1*013 tags
KIR2DS1*002, KIR2DS5*002, and KIR2DL5A*001, and
KIR2DL4*00501 tags KIR2DS1*002, KIR2DS5*002, and
KIR2DL5A*001. KIR2DL4, KIR3DL1/S1, and KIR3DL2
have a particularly high number of alleles included in
haplotypes in strong LD (Table 3). Interestingly, these
associations can extend across relatively low pairwise LD
between loci (high PPV, high NPV, and low D′). For
example, KIR3DL1/S1*013 tags KIR2DL4*00501 and
KIR3DL2*007 and KIR2DL4*00501 tags KIR3DL1/
KIR3DS1*013 and KIR3DL2*007 (Table 4).
More haplotypes in high LD are found in the telomeric
region (see allele association in Table 3 and haplotype in
Table 4). Most of them involve KIR2DL4, KIR3DL1, and
KIR3DL2. Seven telomeric haplotypes explain most of the
2×2 associations observed (Table 4). Two additional
extended haplotypes involved different genes (Table 4).
One points to the potential specificity of the association
between KIR3DL2*011 and KIR2DS4*003 in the context
of KIR2DL4*00801, and the other extended haplotype
involves a KIR3DS1 allele (KIR2DL4*00501–KIR3DL1/
S1*013–KIR2DL5A*001–KIR2DS5*002–KIR2DS1*002–
KIR3DL2*007). Table 4 provides a list of extended
haplotypes in KIR genes.
Discussion
In this study, LD was analyzed at two levels: the structural
presence or absence of KIR genes in haplotypes and the
allelic variation of KIR genes. A tagging approach
demonstrated that the strongest LD, at both the structural
and allelic levels, is found within the centromeric region
from KIR3DL3 to KIR2DL1 and within the telomeric
region from KIR2DL4 to KIR3DL2. This LD pattern was
used to identify the tagging properties of specific genes and
alleles, and a series of tagging associations were presented.
These patterns reduced the number of markers that must be
considered in the association analysis. Using predictive values
to assess LD in KIR polymorphisms is complementary to
classical r2 and D′ and aids in efforts to evaluate the genes or
alleles expected to be found together due to LD based on
specific KIR associations with diseases.
To our knowledge, this study is the largest one using a
familial pedigree design to define KIR haplotypes. Moreover,
it was performed using one of the most homogeneous
European populations, as all Northern Irish families are of
European ancestry, with very little history of immigration.
Compared to a previous report on Irish families (Middleton et
al. 2007), the number of haplotypes studied increased more
than 33% (from 308 to 416 founder haplotypes), providing a
more accurate dataset for a more representative and more
detailed description of LD. In previous family-based studies
of LD in the KIR region, the sample sizes, heterogeneity of
the families, and lower typing resolution did not permit a
comprehensive quantification of LD (Martin et al. 2008;
Whang et al. 2005). The present results were obtained using
a systematic approach. They reflect the major characteristics
of KIR LD in populations of Northern European ancestry.
Although not typed to the allelic level, the analysis of LD by
Whang et al. (2005) in families of Korean ancestry suggests
that LD in KIR is affected by the variation of the proportions
of A and B haplotypes in both the telomeric and centromeric
regions.
Regarding LD between genes, the use of the tag
approach confirms previous classical LD findings (Norman
et al. 2004; Single et al. 2008) as well as nonpairwise
associations such as KIR2DL2–KIR2DS3–KIR2DL5B
(Ordonez et al. 2008). Such associations can be used to
detect genotyping error when unexpected associations are
found. At the structural level, we observed the same LD
pattern for KIR3DL1 and KIR3DS1 as that of Martin et al.
(2008). KIR3DL1 and KIR3DS1 were presented as the two
alleles of the KIR3DL1/S1 locus because allele typing was
performed in the present study. To clarify the multiple
features of LD in KIR, LD was formulated in terms of
positive and negative predictive value. Strong LD between
KIR genes (as measured by D′) is driven by specific allelic
associations. The present data considerably update the
previous allelic associations described by Shilling et al.
(Shilling et al. 2002), as the improvement of typing
techniques and the greater number of families studied
Centromeric haplotype
KIR2DS2*POS–KIR2DL2*001–KIR2DL5B*002–KIR2DS3*00103–KIR2DL1*00401
Telomeric haplotypes
KIR2DL4*011–KIR3DL1*005–KIR2DS4*003–KIR3DL2*003
KIR2DL4*00802–KIR3DL1*004–KIR2DS4*006– KIR3DL2*005
KIR2DL4*00801–KIR3DL1*00101–KIR2DS4*003–KIR3DL2*001
KIR2DL4*00103–KIR3DL1*008–KIR2DS4*003–KIR3DL2*009
KIR2DL4*00102–KIR3DL1*01502/*002–KIR2DS4*00101–KIR3DL2*002
KIR2DL4*00801–KIR2DS4*003–KIR3DL2*011
KIR2DL4*00501–KIR3DS1*013–KIR2DL5A*001–KIR2DS5*002–KIR2DS1*002–KIR3DL2*007
Table 4 Haplotypes exhibiting
the strongest KIR allele
associations in the KIR gene
cluster
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allowed for a more comprehensive analysis. Although LD
between alleles of KIR2DL3, KIR2DL1, KIR3DL1, and
KIR3DL2 was studied by Shilling et al., many more
associations are presented here. Consequently, very few
direct comparisons between the results can be made. The
most significant (p<0.0001) positive LD components
reported by Shilling et al. (2002) are found among our
results: KIR3DL2*003 tags KIR3DL1*004, KIR3DL2*005
tags KIR3DL1*004, KIR3DL2*007 tags KIR3DS1
(KIR3DL1/S1*013 in present study), and KIR2DL1*003
(refined to be *00302 here) tags KIR2DL3*001. In
addition, because haplotypes were experimentally deduced,
no “blank” alleles had to be defined in the present study. By
looking only at the most frequent haplotypes, LD associations
are more robust because a minimal frequency of 5%
corresponds to a minimal number of haplotypes of more than
20. In addition, the associations were quantified rather than
qualitatively evaluated for their statistical significance (H0: D
′≠0). Such approaches allow the identification of extended
KIR allele haplotypes that are in strong LD. These are the
KIR equivalents of the extended or conserved haplotypes of
HLA alleles (most-frequent-most-in-LD haplotypes, also
termed “ancestral haplotypes” and “complotypes” (Alper et
al. 1992; Dawkins et al. 1983)).
For association studies, analysis at the DNA level of the
presence or absence of KIR genes, or structural variation
such as CNV, should take into account unexpressed and/or
untranscribed alleles, as well as the genetic structure within
these complex loci, to make sense of observed associations
with diseases. Furthermore, the same approach can be used
for various subgroups of KIR haplotypes, such as the A and
B haplotypes separately, the presence or absence of
KIR2DS4, high and low expression KIR3DL1 alleles, or
expressed and unexpressed KIR2DS4 alleles. Such analyses
would provide an alternative view of the LD associations
between KIR alleles conditioned by the characteristics of
the subgroup of haplotypes. When computed between
polymorphic loci, LD appears to be much smaller in A
haplotypes than in B haplotypes. In B haplotypes, an
unrevealed LD component between KIR2DS2 (and KIR2DL2)
and telomeric genes is observed. KIR2DS1 and KIR2DS2 are
strongly associated in B haplotypes (D′=0.96, data not shown
(Gourraud et al. 2008)). Strong LD components are also found
in KIR2DS4* negative haplotypes. Because PPV and NPV
also can be computed in any subset of haplotypes in
populations of various ancestries, the PPV/NPV-based
approach of LD can be applied to any subset of haplotypes.
Dedicated software is needed to make such analyses easier to
achieve.
The numerous statistics presented here are relevant for
association studies. They provide a simplified, working
approach and an overview of the associations between KIR
polymorphisms. For example, two studies suggested that
KIR2DS1 is associated with psoriasis vulgaris (Luszczek et
al. 2004; Ploski et al. 2006), but another paper suggested
that both KIR2DS1 and KIR2DL5 are associated with this
disease (Suzuki et al. 2004). The data in Tables S1 to S4
shed light on these findings, revealing a strong association
between the presence of KIR2DS1 and the presence of
KIR2DL5A (PPV=96.5%, NPV=99.7%) and between the
presence of KIR2DS1with the absence of KIR2DL5B
(PPV=73.3%), although KIR2DL5B can be present togeth-
er with KIR2DS1 (NPV=10.8%). As hypothesized for
extended HLA haplotypes, these KIR haplotypes might
have specific immunopathological properties that should be
further studied as potentially coexpressed receptors. PPVs
and NPVs account for both allele frequencies and LD
structure. In addition, PPVs and NPVs describe LD in ways
that are easier to express in natural language than r2 and D′.
Classically, high LD can be created by genetic drift, selection,
and the founder effect. Although our sample of KIR families
is the largest ever published, the sample size may be not
sufficient to observe all possible haplotypes. Due to the
sampling effect, this can result in an underestimation of the
KIR haplotype diversity and an overestimation of LD.
The associations between KIR revealed in the present
genetic study also can be of specific relevance for
expression and functional studies. For example, Pando et
al. (2003) suggested that the KIR3DL1*004 protein is
poorly expressed at cell surfaces due to substitution at
position 86 in Ig domain 0 and position 182 in Ig domain 1.
The present data indicated that the KIR3DL1/S1*004 allele
is embedded in the haplotype KIR2DL4*00802–KIR3DL1/
S1*004–KIR2DS4*006–KIR3DL2*005, suggesting that
KIR3DL2*005 and/or KIR2DL4*00802 might play a more
significant role in compensating for the poorly expressed
KIR3DL1 protein. Because the absence of a KIR gene must
be taken as a null allele at a given locus, it is less important
to define a KIR gene than to perform typing at the allelic
level. Mathematically and for geneticists, the absence of a
gene may be treated formally as an allele. With regard to
immunological relevance, the absence of a gene should be
considered as equivalent to alleles with no or poor
expression.
Family approaches require great effort, and samples of
unrelated individuals also may be of interest in studying LD in
KIR. Similar analyses performed with estimated haplotype
frequencies offer more accessible opportunities to challenge
LD findings in non-Caucasian populations using designs
based on families and/or unrelated individuals with (Single et
al. 2008; Yoo et al. 2007) or without (Gourraud et al. 2007) a
priori assumptions on the possible haplotypes. These
techniques are much more appropriate than the use of
Arlequin (Excoffier et al. 2005) for KIR, as performed when
PYPOP, HAPLO-IHP, ESTIHAPLO software were not
available (Shilling et al. 2002). The LD data can provide a
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framework of the plausible gene structural haplotypes of the
KIR region. Assuming that all the gene structural haplotypes of
the centromeric and telomeric regions could be combined, the
extent of structural variation would reach a maximum of 169
haplotypes. Bringing allelic diversity to these theoretically
possible gene structural haplotypes would greatly help software
to handle the possible haplotype diversity. In addition, starting
values for expectation–maximization algorithms can adequate-
ly reflect the distribution of KIR haplotype diversity of the three
most frequent gene structural haplotypes in the centromeric
region with the two most frequent gene structural haplotypes in
the telomeric region. The 418 haplotypes experimentally
deduced in the present study highlights the great structural
diversity of the KIR cluster, which can be underestimated in
studies with smaller sample sizes.
Our description of LD in the KIR region suggests that
meiotic recombination combines with an ancestral core
diversity to create new KIR phenotypes upon which natural
selection and genetic drift regenerate LD. Our findings shed
light on the biological implications of KIR gene associa-
tions in terms of the potential balance between inhibitory
and activating effects. We hypothesize that selection would
favor specific combinations of activating and inhibitory
KIR genes and alleles. Our findings also suggest that the
distinction between genes and alleles is artificial, as
recently observed by Norman et al. (2009). The results
clearly show that using the notion of blocks to describe the
complex structure of LD is a good first step. For the sake of
simplicity, we describe KIR LD using the two regions
where the strongest associations occur, but this does not
exclude other LD associations between these two regions.
For example, at the allelic level, we observed that
KIR2DL4*011 is in LD with KIR2DL1*00302 (PPV=
65%, NPV=67%, D′=0.44; data not shown) in addition to
a low LD averaged over all allele pairs between KIR2DL4
and KIR2DL1 (D′=0.22).
LD refers to the complex nonrandom association of
genetic polymorphisms. The various dimensions of LD in
such a complex gene cluster as the KIR region is difficult to
summarize. LD may be quantified in order to adequately
interpret statistical associations between genetic polymor-
phisms in genotypes. The PPV/NPV-based LD analysis
presented here may be used to supplement classical
pairwise analyses by identifying the extended haplotypes
that are the best candidates for conferring differential
genetic risks to human diseases. In turn, such an approach
may provide an evolutionary overview of the genetic
control of the activating/inhibitory balance of NK cell
activity in the immune response.
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